Department of Applied Biology, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan.
Kansai Gakken Laboratory, Kankyo Eisei Yakuhin Co. Ltd., Seika-cho, Kyoto 619-0237, Japan.
Int J Mol Sci. 2021 Jan 6;22(2):491. doi: 10.3390/ijms22020491.
Amyotrophic lateral sclerosis (ALS) is the third most common neurodegenerative disorder and is sometimes associated with frontotemporal dementia. Charcot-Marie-Tooth disease (CMT) is one of the most commonly inherited peripheral neuropathies causing the slow progression of sensory and distal muscle defects. Of note, the severity and progression of CMT symptoms markedly vary. The phenotypic heterogeneity of ALS and CMT suggests the existence of modifiers that determine disease characteristics. Epigenetic regulation of biological functions via gene expression without alterations in the DNA sequence may be an important factor. The methylation of DNA, noncoding RNA, and post-translational modification of histones are the major epigenetic mechanisms. Currently, is emerging as a useful ALS and CMT model. In this review, we summarize recent studies linking ALS and CMT to epigenetic regulation with a strong emphasis on approaches using models.
肌萎缩侧索硬化症(ALS)是第三大常见的神经退行性疾病,有时与额颞叶痴呆有关。Charcot-Marie-Tooth 病(CMT)是最常见的遗传性周围神经病之一,导致感觉和远端肌肉缺陷缓慢进展。值得注意的是,CMT 症状的严重程度和进展差异很大。ALS 和 CMT 的表型异质性表明存在决定疾病特征的修饰因子。通过基因表达而不改变 DNA 序列来调节生物功能的表观遗传可能是一个重要因素。DNA、非编码 RNA 的甲基化和组蛋白的翻译后修饰是主要的表观遗传机制。目前, 已成为一种有用的 ALS 和 CMT 模型。在这篇综述中,我们总结了最近将 ALS 和 CMT 与表观遗传调控联系起来的研究,重点介绍了使用 模型的方法。